Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 38,900 shares of the business’s stock in a transaction on Wednesday, January 22nd. The stock was acquired at an average cost of $0.77 per share, for a total transaction of $29,953.00. Following the transaction, the chief executive officer now directly owns 4,203,689 shares in the company, valued at $3,236,840.53. The trade was a 0.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Grigorios Siokas also recently made the following trade(s):
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were bought at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The shares were bought at an average price of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The stock was bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were bought at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Stock Down 0.7 %
Shares of NASDAQ:COSM opened at $0.78 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The business’s 50 day moving average is $0.73 and its 200 day moving average is $0.90. The stock has a market cap of $18.23 million, a P/E ratio of -0.32 and a beta of 5.57. Cosmos Health Inc. has a 52-week low of $0.47 and a 52-week high of $1.58.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- What is a Dividend King?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is the Australian Securities Exchange (ASX)
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.